Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh
· Delayed Price · Currency is BDT 57.80
-2.60 (-4.30%)
At close: Apr 9, 2025
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 6.33 billion as of April 11, 2025. Its market cap has decreased by -35.98% in one year.
Market Cap
6.33B
Enterprise Value
11.14B
Revenue
7.98B
Ranking
n/a
PE Ratio
15.00
Stock Price
57.80
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 6.33B, an increase of 123.11%. That is a compound annual growth rate of 38.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2025 | 6.33B | 21.19% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grameenphone | 433.18B |
| Square Pharmaceuticals PLC. | 192.09B |
| British American Tobacco Bangladesh Company | 175.39B |
| Walton Hi-Tech Industries | 141.86B |
| Robi Axiata PLC. | 136.71B |
| Bangladesh Export Import Company | 103.85B |
| BRAC Bank PLC. | 88.66B |
| Berger Paints Bangladesh | 82.89B |